• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome.

作者信息

Taylor C M, Milford D V, Rose P E, Roy T C, Rowe B

机构信息

Department of Nephrology, Childrens' Hospital, Birmingham, UK.

出版信息

Pediatr Nephrol. 1990 Jan;4(1):59-61. doi: 10.1007/BF00858441.

DOI:10.1007/BF00858441
PMID:2206883
Abstract

Blood group P1 expression was scored by direct agglutination in 32 patients who had previously developed post-enteropathic haemolytic uraemic syndrome (HUS). Sixty-six children of similar ages undergoing venepuncture for other renal disorders acted as controls. The expression of P1 in controls was that expected from the normal caucasian population, 23% being negative. By contrast, there was an excess of HUS patients with weak or absent expression of P1 (chi 2 for linear trend 5.45, P less than 0.02), and this was particularly evident in those with a poor outcome. Verotoxin (VT), which is associated with HUS, requires the terminal disaccharide of the P1 antigen to bind to cells, and after internalization disrupts the transcription of ribonucleic acid. Mature erythrocytes do not synthesize protein and may be toxin resistant. We postulate that strong expression of P1 antigen may promote the binding of VT to red cells and thus reduce the dose to vulnerable nucleated endothelial cells. P1 positivity may be protective, and P1 negativity a risk factor in HUS.

摘要

相似文献

1
The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome.
Pediatr Nephrol. 1990 Jan;4(1):59-61. doi: 10.1007/BF00858441.
2
Erythrocyte P1 group antigen expression in VTEC-associated hemolytic uremic syndrome.
Clin Nephrol. 1999 Feb;51(2):73-6.
3
Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. The Osaka HUS Critical Care Study Group.B 型血能预防溶血性尿毒综合征吗?对 1996 年阪井大肠杆菌 O157:H7(产志贺毒素大肠杆菌 O157)感染疫情的分析。大阪溶血性尿毒综合征重症监护研究小组。
J Infect. 2000 Jul;41(1):45-9. doi: 10.1053/jinf.2000.0677.
4
Haemolytic uraemic syndrome: prognostic factors.溶血性尿毒症综合征:预后因素
Clin Lab Haematol. 2000 Feb;22(1):11-4. doi: 10.1046/j.1365-2257.2000.00272.x.
5
P1 blood group antigen expression and epidemic hemolytic uremic syndrome.P1血型抗原表达与流行性溶血尿毒综合征
Pediatr Nephrol. 1995 Oct;9(5):612-3. doi: 10.1007/BF00860953.
6
A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.对加拿大溶血尿毒综合征患儿中接触产志贺毒素大肠杆菌情况的前瞻性研究。加拿大儿科肾脏疾病研究组联合调查人员。
Epidemiol Infect. 1993 Feb;110(1):1-7. doi: 10.1017/s0950268800050615.
7
A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection.磷霉素治疗在预防产志贺毒素大肠杆菌感染相关溶血尿毒综合征中的作用。
Int J Antimicrob Agents. 2015 Nov;46(5):586-9. doi: 10.1016/j.ijantimicag.2015.08.006. Epub 2015 Sep 9.
8
ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.ABO和P1血型抗原表达、stx基因型与儿童大肠杆菌O157:H7感染的结局
J Infect Dis. 2002 Jan 15;185(2):214-9. doi: 10.1086/338480. Epub 2002 Jan 3.
9
Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.散发性溶血尿毒综合征病例,与粪便中的细胞毒素及产细胞毒素大肠杆菌有关。
Lancet. 1983 Mar 19;1(8325):619-20. doi: 10.1016/s0140-6736(83)91795-6.
10
Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan.日本成年女性中由产志贺毒素大肠杆菌感染引起的溶血尿毒综合征风险。
Epidemiol Infect. 2016 Apr;144(5):952-61. doi: 10.1017/S0950268815002289. Epub 2015 Oct 16.

引用本文的文献

1
Blood Groups in Infection and Host Susceptibility.感染与宿主易感性中的血型
Clin Microbiol Rev. 2015 Jul;28(3):801-70. doi: 10.1128/CMR.00109-14.
2
Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.大肠埃希菌O157:H7、其他产志贺毒素大肠埃希菌与儿童溶血尿毒综合征
Can J Infect Dis. 1995 Mar;6(2):105-10. doi: 10.1155/1995/803560.
3
Shiga toxin pathogenesis: kidney complications and renal failure.志贺毒素发病机制:肾脏并发症和肾衰竭。

本文引用的文献

1
BIOCHEMISTRY OF ORGAN GLYCOLIPIDS. III. THE STRUCTURES OF HUMAN KIDNEY CEREBROSIDE SULFURIC ESTER, CERAMIDE DIHEXOSIDE AND CERAMIDE TRIHEXOSIDE.器官糖脂的生物化学。III. 人肾脑硫苷脂、二己糖神经酰胺和三己糖神经酰胺的结构
J Biochem. 1964 Apr;55:365-70. doi: 10.1093/oxfordjournals.jbchem.a127896.
2
Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.志贺氏菌腹泻的发病机制。IX. 志贺氏菌毒素的简化高产纯化以及利用亚基特异性单克隆和多克隆抗体对亚基组成和功能的表征。
J Exp Med. 1984 Dec 1;160(6):1767-81. doi: 10.1084/jem.160.6.1767.
3
Curr Top Microbiol Immunol. 2012;357:105-36. doi: 10.1007/82_2011_172.
4
Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro.志贺毒素2e在体内和体外与猪红细胞的结合
Infect Immun. 2003 Sep;71(9):5194-201. doi: 10.1128/IAI.71.9.5194-5201.2003.
5
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.产志贺毒素大肠杆菌感染的发病机制与诊断
Clin Microbiol Rev. 1998 Jul;11(3):450-79. doi: 10.1128/CMR.11.3.450.
6
P1 blood group antigen expression and epidemic hemolytic uremic syndrome.P1血型抗原表达与流行性溶血尿毒综合征
Pediatr Nephrol. 1995 Oct;9(5):612-3. doi: 10.1007/BF00860953.
7
Differing outcomes of Escherichia coli O157 colitis in identical twins.同卵双胞胎中大肠杆菌O157结肠炎的不同结局。
Pediatr Nephrol. 1993 Dec;7(6):771-2. doi: 10.1007/BF01213351.
8
Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro.有证据表明,大肠杆菌产生的志贺毒素(类志贺毒素)在体外可与人红细胞的P血型抗原结合。
Infect Immun. 1994 Aug;62(8):3337-47. doi: 10.1128/iai.62.8.3337-3347.1994.
9
Racial incidence of hemolytic uremic syndrome.溶血性尿毒症综合征的种族发病率。
Pediatr Nephrol. 1994 Oct;8(5):545-7. doi: 10.1007/BF00858122.
10
Racial incidence of hemolytic-uremic syndrome.溶血尿毒综合征的种族发病率。
Pediatr Nephrol. 1995 Jun;9(3):401. doi: 10.1007/BF02254233.
Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.
在美国,与出血性结肠炎相关的大肠杆菌O157:H7菌株会产生一种志贺氏痢疾杆菌1型(志贺毒素)样细胞毒素。
Lancet. 1983 Mar 26;1(8326 Pt 1):702. doi: 10.1016/s0140-6736(83)91987-6.
4
Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.散发性溶血尿毒综合征病例,与粪便中的细胞毒素及产细胞毒素大肠杆菌有关。
Lancet. 1983 Mar 19;1(8325):619-20. doi: 10.1016/s0140-6736(83)91795-6.
5
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.特发性溶血尿毒综合征与产志贺毒素大肠杆菌感染之间的关联。
J Infect Dis. 1985 May;151(5):775-82. doi: 10.1093/infdis/151.5.775.
6
Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.1型痢疾志贺氏菌产生的志贺毒素碳水化合物受体的鉴定。
J Biol Chem. 1987 Feb 5;262(4):1779-85.
7
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.纯化的和重组大肠杆菌产生的志贺毒素在体外与糖脂的结合。
J Biol Chem. 1987 Jun 25;262(18):8834-9.
8
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes.溶血尿毒综合征患儿中产生维罗毒素的大肠杆菌菌株及其用特异性DNA探针进行的检测
J Med Microbiol. 1988 Apr;25(4):237-43. doi: 10.1099/00222615-25-4-237.
9
Location of adhesion sites for P-fimbriated and for 075X-positive Escherichia coli in the human kidney.
Microb Pathog. 1986 Apr;1(2):169-80. doi: 10.1016/0882-4010(86)90019-7.